Lexeo Therapeutics Statistics

Total Valuation

LXEO has a market cap or net worth of $258.65 million. The enterprise value is $131.97 million.

Market Cap	258.65M
Enterprise Value	131.97M

Important Dates

The next confirmed earnings date is Thursday, August 14, 2025, before market open.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

LXEO has 54.00 million shares outstanding. The number of shares has increased by 80.52% in one year.

Current Share Class	54.00M
Shares Outstanding	54.00M
Shares Change (YoY)	+80.52%
Shares Change (QoQ)	+31.59%
Owned by Insiders (%)	0.28%
Owned by Institutions (%)	48.20%
Float	37.71M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.78
P/TBV Ratio	1.85
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.43, with a Debt / Equity ratio of 0.06.

Current Ratio	4.43
Quick Ratio	4.21
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,045.92

Financial Efficiency

Return on equity (ROE) is -75.32% and return on invested capital (ROIC) is -47.77%.

Return on Equity (ROE)	-75.32%
Return on Assets (ROA)	-41.91%
Return on Invested Capital (ROIC)	-47.77%
Return on Capital Employed (ROCE)	-85.43%
Revenue Per Employee	n/a
Profits Per Employee	-$1.59M
Employee Count	72
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -60.60% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-60.60%
50-Day Moving Average	4.22
200-Day Moving Average	4.78
Relative Strength Index (RSI)	58.42
Average Volume (20 Days)	398,355

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	-74.09M
Operating Income	-123.42M
Pretax Income	-69.42M
Net Income	-114.17M
EBITDA	-122.82M
EBIT	-123.42M
Earnings Per Share (EPS)	-$3.20

Full Income Statement

Balance Sheet

The company has $132.89 million in cash and $8.91 million in debt, giving a net cash position of $123.98 million or $2.30 per share.

Cash & Cash Equivalents	132.89M
Total Debt	8.91M
Net Cash	123.98M
Net Cash Per Share	$2.30
Equity (Book Value)	138.22M
Book Value Per Share	2.56
Working Capital	108.47M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$95.07 million and capital expenditures -$191,000, giving a free cash flow of -$95.26 million.

Operating Cash Flow	-95.07M
Capital Expenditures	-191,000
Free Cash Flow	-95.26M
FCF Per Share	-$1.76

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LXEO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-80.52%
Shareholder Yield	-80.52%
Earnings Yield	-44.61%
FCF Yield	-37.22%

Analyst Forecast

The average price target for LXEO is $17.17, which is 258.46% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$17.17
Price Target Difference	258.46%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	1.39%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1